Page last updated: 2024-08-23

1-methyl-4-phenylpyridinium and Chronic Disease

1-methyl-4-phenylpyridinium has been researched along with Chronic Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
German, DC; Liang, CL; Manzino, L; Sonsalla, PK; Yazdani, U; Zeevalk, GD	1

Other Studies

1 other study(ies) available for 1-methyl-4-phenylpyridinium and Chronic Disease

Article	Year
Rat model of Parkinson's disease: chronic central delivery of 1-methyl-4-phenylpyridinium (MPP+). Experimental neurology, 2006, Volume: 200, Issue:1 Topics: 1-Methyl-4-phenylpyridinium; Animals; Chronic Disease; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Injections, Intraventricular; Male; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley; Survival Rate	2006

Article

Year

Rat model of Parkinson's disease: chronic central delivery of 1-methyl-4-phenylpyridinium (MPP+).

Experimental neurology, 2006, Volume: 200, Issue:1

Topics: 1-Methyl-4-phenylpyridinium; Animals; Chronic Disease; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Injections, Intraventricular; Male; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley; Survival Rate

2006